Recurrent co-alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis.
Saved in:
| Title: | Recurrent co-alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis. |
|---|---|
| Authors: | Fazio M; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA, USA., van Rooijen E; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA, USA., Mito JK; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Modhurima R; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Weiskopf E; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Yang S; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Zon LI; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA, USA. |
| Source: | Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2021 May; Vol. 34 (3), pp. 641-647. Date of Electronic Publication: 2020 Nov 17. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-148X (Electronic) Linking ISSN: 17551471 NLM ISO Abbreviation: Pigment Cell Melanoma Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
